BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11998209)

  • 1. [Cytological history of 148 women presenting with invasive cervical cancer].
    Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
    Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytological study of 191 women with invasive cancer of the uterine cervix in Brittany, France].
    Lavoué V; Gautier C; Piette C; Porée P; Mesbah H; Foucher F; Vialard J; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):396-403. PubMed ID: 19473783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The screening histories of women with invasive cervical cancer, Connecticut.
    Janerich DT; Hadjimichael O; Schwartz PE; Lowell DM; Meigs JW; Merino MJ; Flannery JT; Polednak AP
    Am J Public Health; 1995 Jun; 85(6):791-4. PubMed ID: 7762711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant.
    Uyar DS; Eltabbakh GH; Mount SL
    Gynecol Oncol; 2003 May; 89(2):227-32. PubMed ID: 12713984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive cervical cancer: the Connecticut experience.
    Schwartz PE; Hadjimichael O; Lowell DM; Merino MJ; Janerich D
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 2):1105-9. PubMed ID: 8885794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pap smears in women with endometrial carcinoma.
    Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
    Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications.
    Coleman DV; Poznansky JJ
    Cytopathology; 2006 Jun; 17(3):127-36. PubMed ID: 16719855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
    Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
    Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstacles to the early detection of endocervical adenocarcinoma.
    Kalir T; Simsir A; Demopoulos HB; Demopoulos RI
    Int J Gynecol Pathol; 2005 Oct; 24(4):399-403. PubMed ID: 16175089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears.
    Rha SH; Dong SM; Jen J; Nicol T; Sidransky D
    Int J Cancer; 2001 Aug; 93(3):424-9. PubMed ID: 11433409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of cytological findings in abnormal cervical smears by cytohistologic comparison.
    Mostafa MG; Srivannaboon S; Rachanawutanon M
    Indian J Pathol Microbiol; 2000 Jan; 43(1):23-9. PubMed ID: 12583415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark.
    Olesen F
    Int J Epidemiol; 1988 Sep; 17(3):501-8. PubMed ID: 3209326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present standards for cervical cancer screening.
    O'Meara AT
    Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.